The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma
dc.contributor.author | Pridham, Kevin J. | en |
dc.contributor.author | Varghese, Robin T. | en |
dc.contributor.author | Sheng, Zhi | en |
dc.date.accessioned | 2018-03-14T15:08:35Z | en |
dc.date.available | 2018-03-14T15:08:35Z | en |
dc.date.issued | 2017-12-15 | en |
dc.description.abstract | Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) plays a critical role in the pathogenesis of cancer including glioblastoma, the most common and aggressive form of brain cancer. Targeting the PI3K pathway to treat glioblastoma has been tested in the clinic with modest effect. In light of the recent finding that PI3K catalytic subunits (PIK3CA/p110 alpha, PIK3CB/p110 beta, PIK3CD/p110 delta, and PIK3CG/p110 gamma) are not functionally redundant, it is imperative to determine whether these subunits play divergent roles in glioblastoma and whether selectively targeting PI3K catalytic subunits represents a novel and effective strategy to tackle PI3K signaling. This article summarizes recent advances in understanding the role of PI3K catalytic subunits in glioblastoma and discusses the possibility of selective blockade of one PI3K catalytic subunit as a treatment option for glioblastoma. | en |
dc.description.version | Published version | en |
dc.format.extent | ? - ? (8) page(s) | en |
dc.identifier.doi | https://doi.org/10.3389/fonc.2017.00312 | en |
dc.identifier.issn | 2234-943X | en |
dc.identifier.orcid | Sheng, Z [0000-0002-0029-8666] | en |
dc.identifier.uri | http://hdl.handle.net/10919/82497 | en |
dc.identifier.volume | 7 | en |
dc.language | English | en |
dc.publisher | Frontiers | en |
dc.relation.uri | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000418035800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=930d57c9ac61a043676db62af60056c1 | en |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Oncology | en |
dc.subject | phosphatidylinositol-4,5-bisphosphate 3-kinase | en |
dc.subject | glioblastoma | en |
dc.subject | class IA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunits | en |
dc.subject | PIK3CA | en |
dc.subject | PIK3CB | en |
dc.subject | PIK3CD | en |
dc.subject | CHRONIC LYMPHOCYTIC-LEUKEMIA | en |
dc.subject | REPORT PRIMARY BRAIN | en |
dc.subject | RECURRENT GLIOBLASTOMA | en |
dc.subject | UNITED-STATES | en |
dc.subject | PIK3CA GENE | en |
dc.subject | PHASE-II | en |
dc.subject | PHOSPHOINOSITIDE 3-KINASE | en |
dc.subject | METABOLIC-REGULATION | en |
dc.subject | P110-ALPHA ISOFORM | en |
dc.subject | ONCOGENIC MUTATION | en |
dc.title | The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma | en |
dc.title.serial | Frontiers in Oncology | en |
dc.type | Article - Refereed | en |
dc.type.other | Review | en |
dc.type.other | Journal | en |
pubs.organisational-group | /Virginia Tech | en |
pubs.organisational-group | /Virginia Tech/All T&R Faculty | en |
pubs.organisational-group | /Virginia Tech/Faculty of Health Sciences | en |
pubs.organisational-group | /Virginia Tech/University Research Institutes | en |
pubs.organisational-group | /Virginia Tech/University Research Institutes/Fralin Life Sciences | en |
pubs.organisational-group | /Virginia Tech/University Research Institutes/Fralin Life Sciences/Fralin Affiliated Faculty | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.pdf
- Size:
- 355.47 KB
- Format:
- Adobe Portable Document Format
- Description:
- Publisher's Version
License bundle
1 - 1 of 1
- Name:
- VTUL_Distribution_License_2016_05_09.pdf
- Size:
- 18.09 KB
- Format:
- Adobe Portable Document Format
- Description: